BOLT vs IT · rev $7.7M vs P/E 16, rev $6.27B
Bolt Biotherapeutics (BOLT) versus Gartner Inc (IT) — a side-by-side from cached financials, not a winner call.
Bolt Biotherapeutics (BOLT) is a biotechnology company listed on US.
Gartner Inc (IT) is a information technology services company listed on US.
Latest reported BOLT revenue for 2024-12-31 was $7.7M. Net income was -$63.1M. Revenue was down 2.4% from 2023-12-31 to 2024-12-31. BOLT currently screens at market cap $11.3M.
Latest reported IT revenue for 2024-12-31 was $6.27B. Net income was $1.25B. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. IT currently screens at market cap $11.03B and trailing P/E 16.3.
BOLT currently screens at market cap $11.3M. IT currently screens at market cap $11.03B and trailing P/E 16.3.
Not investment advice. Open the BOLT and IT stock pages for the full models.
Not investment advice.